Home > Products > CD3 & DLL3
> Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (scIgG)
Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (scIgG) (CAT#: SCIGG-076)
Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD3 and anti-DLL3 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget T cells to tumor cells. It is designed for the research of Lung cancer; Pancreatic cancer; Skin cancer; Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (scIgG) (SCIGG-076). Click the button below to contact us or submit your feedback about this product.